Technical Analysis for NTII - Neurobiolgl Tech Inc

Grade Last Price % Change Price Change
grade D 0.0047 -6.00% -0.0003
NTII closed down 6.0 percent on Wednesday, September 18, 2019, on 4.32 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical NTII trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.00%
Crossed Above 20 DMA Bullish -6.00%
Stochastic Buy Signal Bullish -6.00%
Pocket Pivot Bullish Swing Setup -6.00%
Wide Range Bar Range Expansion -6.00%

Older signals for NTII ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Neurobiological Technologies, Inc. (NTI), was previously focused on developing investigational drugs to treat human diseases. On October 27, 2009, the Company’s stockholders approved the dissolution of the Company pursuant to a plan of complete liquidation and dissolution earlier approved by its board of directors on August 27, 2009 (the Plan of Dissolution). As a Company in dissolution, NTI was not allowed to carry on any business except for the purpose of winding down the business and affairs of the Company. On December 17, 2009, the Company filed a certificate of dissolution with the Secretary of State of the State of Delaware (the Certificate of Dissolution). As of June 30, 2010, NTI retains an interest in an investigational drug called XERECEPT, which is a synthetic preparation of Corticotropin-Releasing Factor, a natural human peptide. XERECEPT is being developed by Celtic Pharma as a treatment for swelling around brain tumors and other cancer indications.
Cancer Law Business Law Corporate Law Liquidation Human Diseases Insolvency Brain Tumors
Is NTII a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.09
52 Week Low 0.002
Average Volume 11,668
200-Day Moving Average 0.0118
50-Day Moving Average 0.0057
20-Day Moving Average 0.0038
10-Day Moving Average 0.0035
Average True Range 0.0008
ADX 15.29
+DI 57.7236
-DI 32.5203
Chandelier Exit (Long, 3 ATRs ) 0.007199999999999999
Chandelier Exit (Short, 3 ATRs ) 0.0054
Upper Bollinger Band 0.0051
Lower Bollinger Band 0.0025
Percent B (%b) 0.85
BandWidth 68.421053
MACD Line -0.0007
MACD Signal Line -0.001
MACD Histogram 0.0003
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0067
Resistance 3 (R3) 0.0069 0.0064 0.0063
Resistance 2 (R2) 0.0064 0.0059 0.0063 0.0062
Resistance 1 (R1) 0.0056 0.0056 0.0054 0.0054 0.0061
Pivot Point 0.0051 0.0051 0.0050 0.0050 0.0051
Support 1 (S1) 0.0043 0.0046 0.0041 0.0041 0.0033
Support 2 (S2) 0.0038 0.0043 0.0037 0.0032
Support 3 (S3) 0.0030 0.0038 0.0031
Support 4 (S4) 0.0028